Endocrine Society launches first open-access journal

January 12, 2017

Washington, DC--The Endocrine Society unveiled the first issue of its Open Access scholarly publication the Journal of the Endocrine Society (JES) today, marking the first time the Society has introduced a new journal under its ownership in nearly 30 years.

The online-only format is specifically intended to rapidly publish emerging science on a variety of endocrinology topics. The articles are available at no cost for non-commercial use to anyone in the world with an Internet connection.

The first issue of JES features research on post-treatment surveillance for thyroid cancer, pregnancy-induced Cushing's syndrome, and advanced methods for measuring testosterone levels in saliva.

The peer-reviewed articles published in JES span the Society's mission to cover advances in basic science, clinical science and clinical practice. JES includes original research as well as reports, mini-reviews, commentaries, tools and methods, datasets and other innovative contributions that advance the endocrinology field.

"Going forward, JES will undoubtedly play a central role in the dissemination of research and knowledge in our field," said Endocrine Society Past-President J. Larry Jameson, MD, PhD, who serves as the journal's first Editor-in-Chief, and is the Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Perelman School of Medicine. "Publishing is rapidly transitioning from bound journals delivered by mail to online sources of information."

The journal's Open Access format allows the Society to publish high-quality scientific research papers without being restricted by the page limitations of a print journal. The new journal creates the opportunity for more scientists to publish their work and offers an avenue for cutting-edge research to advance science and improve medical care.

Readers will continually have access to new content from JES as each article is accepted after peer review and published online. This efficient process is designed to meet the needs of readers who want access to the latest science as well as researchers who want their work to be rapidly reviewed and shared with the public.

JES and digital editions of the Society's other three journals--The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Endocrine Reviews-are now available exclusively through Oxford University Press (OUP) on its new, best-in-class, web platform. The platform allows for improved search and discovery with multimedia integration for optimal viewing on desktop computers, tablets or smartphones. The Society appointed OUP as its digital distributor in July 2016.

The Society also has begun providing published authors with access to Kudos and Altmetric--digital tools that help scientists and researchers to promote and gauge the reach of their published work in real time.

The Society is a scientific publisher of prestigious peer-reviewed journals and an information leader in endocrinology and hormone science. Its journals are well known in the field and are distributed worldwide in print and online editions. The Society's journals contain cutting-edge research across the broad spectrum of endocrine-related topics, creating a greater link between scientific discovery, clinical practice and patient care.

Oxford University Press publishes over 300 academic and research journals covering a broad range of subject areas, two thirds of which are published in collaboration with learned societies and other international organizations. As part of the partnership, OUP also will sell online and print journal subscriptions to the institutional market worldwide, other than the Society's existing markets in Japan.

To learn more about JES or to submit a manuscript, visit https://academic.oup.com/JES.
-end-
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Endocrine Articles from Brightsurf:

Adults with endocrine disorders have an increased risk of heart disease
All adults with endocrine disorders should be tested for high cholesterol and triglycerides to evaluate their risk of heart attack or stroke, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Studies show strong links between the endocrine system and COVID-19 incidence and mortality
COVID-19 and interlinkages to endocrine and metabolic diseases was an important programme topic at the 2020 European Congress of Endocrinology.

More chemicals can be assessed for endocrine disrupting effects
A European guidance document aimed at identifying endocrine disrupting pesticides can--with some modifications--be used to assess other chemicals' endocrine disrupting effects.

Coronavirus damages the endocrine system
People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.

Endocrine Society updates osteoporosis Clinical Practice Guideline
The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture.

Hyperactive FOXA1 reprograms endocrine-resistant breast cancer to become metastatic
A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new therapeutic strategies.

Endocrine Society urges policymakers to follow science on transgender health
A custody case in Texas has sparked heated debate and embroiled state policymakers in public discussions about the diagnosis and appropriate medical treatment of transgender children.

Genetic inequity towards endocrine disruptors
Phthalates are used by industry in plastic products. Their toxic effect on the endocrine system is worrying.

Endocrine disruptors alter female reproduction throughout multiple generations
Endocrine disruptors, hormone-altering chemicals that are widespread in our environment, can shape the brain through four generations, altering offspring's maternal behavior, sexual development and reproduction, according to a new animal study.

Chemicals linked to endocrine disorder in older pet cats
New research suggests that there may be a link between higher levels of per- and polyfluoroalkyl substances (PFAS) in the environment and higher levels of hyperthyroidism in pet cats as they age.

Read More: Endocrine News and Endocrine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.